All
Atopic dermatitis pruritis trial fails
May 23rd 2018Symptomatic relief remains out of reach for many who suffer chronic pruritis. Without drugs specifically approved to treat chronic itch, providers and patients rely on therapies with limited efficacy. Here’s an update of two important clinical trials.
Considering buying a laser for your practice? Check out this how-to-purchase guide.
May 11th 2018Laser technology may be one of the most important purchases for a dermatology practice. Anne Chapas, M.D., of Union Square Laser Dermatology in New York, suggests that physicians do their research before making such an important investment. “I’ve actually seen people go bankrupt because they didn’t know how to use this very expensive laser that they purchased,” she said. Dr. Chapas suggests the following considerations before making your first purchase.
Can I be sued for off-label use within standard of care?
May 10th 2018Is it misuse to use medication for off-label uses? A patient sues after developing facial pain and other symptoms associated with the use of a topical for scabies. Is this physician guilty of practicing medicine outside the standard of care?
Shingles vaccine can last three years, study shows
May 3rd 2018Immune responses to the latest shingles vaccine (Shingrix) last for at least three years after vaccination. The robust immune responses develop and persist in all age groups, according to a recent study in The Journal of Infectious Diseases.
Eczema in fetus and neonates rise with maternal stress
April 23rd 2018Stress factors mothers experience before, during and soon after pregnancy can increase eczema risk in their children, according to a systematic review published Feb. 25, 2018 in The International Journal of Environmental Research and Public Health.
Combination topical treatment reduces psoriasis severity
April 19th 2018The fixed combination of halobetasol and tazarotene topicals significantly reduced the severity of localized disease with a favorable safety profile, accordint to a study published in the Journal of the American Academy of Dermatology.
Immunity persists for at least 3 years after receipt of new shingles vaccine
April 18th 2018Immune responses to the latest shingles vaccine (Shingrix) last for at least three years following vaccination. The robust immune responses develop and persist in all age groups, according to a recent study in The Journal of Infectious Diseases.